SPONSOR
Hospital de Clinicas de Porto Alegre
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Hospital de Clinicas de Porto Alegre is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Chronic Obstructive Pulmonary Disease Severe, Breast Cancer, Diabetic Retinopathy.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hospital de Clinicas de Porto Alegre
How many clinical trials has Hospital de Clinicas de Porto Alegre sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Hospital de Clinicas de Porto Alegre, of which 3 are actively recruiting participants. These trials cover conditions including Chronic Obstructive Pulmonary Disease Severe, Breast Cancer, Diabetic Retinopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hospital de Clinicas de Porto Alegre research focus on?
Hospital de Clinicas de Porto Alegre clinical trials span Chronic Obstructive Pulmonary Disease Severe, Breast Cancer, Diabetic Retinopathy. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hospital de Clinicas de Porto Alegre clinical trial?
To participate in a Hospital de Clinicas de Porto Alegre trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hospital de Clinicas de Porto Alegre trials with current recruitment status updated daily.
Clinical Trials by Hospital de Clinicas de Porto Alegre
NCT04018729 Phase 2, Phase 3
Recruiting
Cell Therapy Associated With Endobronchial Valve
Chronic Obstructive Pulmonary Disease Severe
NCT07823660
Recruiting
Cardio-Oncology Rehabilitation in Breast Cancer Patients Undergoing Chemotherapy
Breast Cancer
NCT07236879
Recruiting
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
Diabetic Retinopathy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology